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Fig. 1. Gene expression of IL10 in M0 (A), M1 (B), and M2 (C) macro-
phages, of IL1ra in M0 (D), M1 (E), and M2 (F) macrophages, of CCL18 in
M0 (G), M1 (H), and M2 (I) macrophages, and of IL6 in M0 (J), M1 (IK), and
M2 (L) macrophages. Each dot represents the effect of one SF donor on the
macrophages with the mean. The dotted line represents the gene
expression without SF.
d Cartilage 22 (2014) S57–S489Fig. 2. – H&E images of infrapatellar fat pad after ACL reconstruction
10 - Arrows label enhanced cellularity, arrowheads identify vascularity,
stars label ﬁbrosis
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ANTI-INFLAMMATORY EFFECT OF RESVERATROL AS A DIETARY
SUPPLEMENT IN AN ANTIGEN-INDUCED ARTHRITIS RAT MODEL.
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Purpose: Inﬂammatory cells like macrophages, lymphocytes and neu-
trophils in hyperplasic synovial tissue have been identiﬁed as key
players in the onset and development of rheumatoid arthritis (RA).
Resveratrol (RSV) is a natural antioxidant with potent immunomodu-
latory and anti-inﬂammatory properties. The aim of this study was to
investigate the preventive effect of dietary resveratrol and its ability to
suppress inﬂammatory arthritis progression in an acute antigen-
induced arthritis (AIA) rat model.
Methods: Six-week-old female Lewis rats were randomized into four
study groups: healthy group (n ¼ 19), AIA group (n ¼ 24), RSV group (n
¼ 26) and diclofenac (DCF) group (n ¼ 17). RSV (2 mg/day) was
administered daily by oral gavage as a dietary supplement beginning
one month before AIA induction until sacriﬁce day, 48 h after intra-
articular injection. DCF (1.2 mg/day) was orally administered three days
before AIA induction until sacriﬁce day. Joint swelling was assessed by
measuring the mediolateral diameter of both right and left knee joints
with a digital calliper. Severity of inﬂammation was evaluated using a
blind damage scoring system (H&E). To characterize inﬂammatory cell
inﬁltration and chemokine levels, CD68, CD3 and MCP-1 expression
were evaluated by immunohistochemistry.
Results: On day 2 after intraarticular injection, RSV animals exhibited
signiﬁcant reduced knee swelling, similar to DCF group, in comparison
to AIA animals (mediolateral diameter mean: RSV 7.775  0.169 mm;
DCF 7.776  0.253 mm, vs. AIA 8.281  0.127 mm; p < 0.05). Accord-
ingly, histopathological evaluation demonstrated a reduction in syno-
vial hyperplasia and cell inﬁltration in both RSV and DCF groups
compared to AIA animals. CD68 and CD3 inﬁltrate was signiﬁcantly
attenuated in RSV rats synovium (0.843  0.369, n ¼ 5 and 1.290 
0.198, n ¼ 19, respectively) compared to AIA group (CD68 3.741 1.428,
n ¼ 5 and CD3 2.868  0.5707, n ¼ 18, p < 0.05), similar to DCF group
(CD68 1.656 0.522, n¼ 13 and CD31.753 0.359, n¼ 15). MCP1 levels
in the synovium were signiﬁcantly attenuated in RSV and DCF groups
compared to AIA animals (3.167  0.2649 and 2.453  0.628, respec-
tively vs. AIA 4.400  0.4922, p < 0.05).
Conclusions: The results of this study suggest that a dietary supple-
ment with the natural antioxidant resveratrol can effectively control
inﬂammation and could exert a protective effect against RA establish-
ment and progression.
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ARTHRITIC SYNOVIAL FLUID INFLUENCES EXPRESSION OF PRO- AND
ANTI-INFLAMMATORY MEDIATORS IN MACROPHAGES
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Y.M. Bastiaansen-Jenniskens z. y IRCCS Galeazzi Orthopaedic Insitute,
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Purpose: Synovitis is a common trait of Osteoarthritis (OA) and Rheu-
matoid Arthritis (RA), with the synovial membrane showing a con-
sistent inﬁltration of immune cells. Macrophages are recruited to the
joint where they induce and maintain the inﬂammatory state by
secreting pro-inﬂammatory mediators. Given the key role of macro-
phages in arthritic pathologies, the aim of this study was to investigate
Abstracts / Osteoarthritis anS290how macrophages react to the stimuli typical of the diseased joint
environment. Therefore, we evaluated the effect of OA and RA synovial
ﬂuid (SF) on the transcriptional expression of pro- and anti-inﬂam-
matory mediators in different macrophage phenotypes.
Methods: SF samples of 6 donors with no joint disease (Ctrl SF) were
bought. SF was also obtained from 10 donors with end-stage knee
osteoarthritis (OA SF) and from 10 donors with rheumatoid arthritis (RA
SF). Monocytes were isolated from the buffy coats of 3 healthy donors
with CD14 positive selection and pooled together. Immediately after
isolation, adherent macrophages were either cultured in non-activating
conditions (M0), stimulated with IFNg and TNFa towards a pro-
inﬂammatory phenotype (M1 activation), or with IL4 towards an anti-
inﬂammatory phenotype (M2 activation). After 12 hours of culture in
M0, M1, or M2 conditions, macrophages were treated with or without
the different types of SF (50% V/V). All samples were cultured for an
additional 12 hours and then harvested to analyze the transcriptional
expression of IL6, TNFa, IL1b, IL10, CCL18, CD206 and IL1Ra. Comparison
among the different types of SF was performed by One-Way ANOVA for
non-parametric data (Kruskal-Wallis test) with a Dunn’s multiple
comparison post hoc test.\
Results: Stimulation of macrophages with IFNg and TNFa resulted in
the upregulation of IL6, TNFa, and IL1b, and in the down-regulation of
CD206 demonstrating that anM1 phenotypewas induced. IL10 was also
upregulated in M1-stimulated cells, probably as a feedback reaction to
the pro-inﬂammatory stimulation. On the other hand, M2 stimulation
induced the expression of CCL18, CD206 and IL1ra conﬁrming the
induction of an M2 phenotype.Compared to Ctrl SF, IL10 gene expres-
sion was decreased in response to RA SF in both M0 (Fig. A) and M2
macrophages (Fig. C). OA SF also decreased IL10, but only in M2 mac-
rophages (Fig. C). OA SF increased IL1ra gene expression in M0, M1, and
M2 macrophages (Figs. D, E, and F). RA SF also increased IL1ra but only
in M0 macrophages (Fig. D). IL6 and CCL18 gene expression were
decreased by RA SF in M2 macrophages (Figs. I and L) compared to Ctrl
SF. No effect was seen regarding these genes by OA SF. TNFa, IL1b, and
CD206 were not affected at all by any type of SF in any of the macro-
phage phenotypes (data not shown).
Conclusions: Compared to Ctrl SF, OA SF decreased pro-inﬂammatory
processes as shown by the decrease in IL10 (which is normally high
when macrophages are in a pro-inﬂammatory environment) and the
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S291increase in IL1ra. This was especially seen in the M2 macrophages,
indicating that OA SF enhances this phenotype. Surprisingly, RA SF also
seemed to decrease pro-inﬂammatory processes as shown by a
decrease of IL10 and an increase of IL1ra, but also by the decrease of IL6.
In conclusion, SF from diseased joints does not induce pro-inﬂamma-
tory processes, even not when from RA joints. Based on our results, SF
from diseased joints might even induce anti-inﬂammatory processes.
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SYNOVIOCYTE INFLAMMATORY RESPONSES TO CALCIUM
PYROPHOSPHATE DIHYDRATE CRYSTALS INVOLVES CD14 AND TLR-4.
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Purpose: Low-grade synovial inﬂammation is seen in the setting of
osteoarthritis (OA), even in early-stages, although the molecular trig-
gers of inﬂammation in OA are as yet unclear. Stimulation of Toll-like
receptors (TLRs) by endogenous molecules released during cartilage
matrix damage and chondrocyte stress is hypothesized to be one
mechanism leading to synovial inﬂammation in OA. We previously
reported that a TLR co-receptor, soluble CD14 (sCD14), is found in
synovial ﬂuid (SF) from patients with early and advanced stage OA, and
can augment responses of ﬁbroblast-like synoviocytes (FLS) to typical
TLR-2 and TLR-4 ligands. The purpose of the current study was to
determine if sCD14 can impact FLS responses to crystalline ligands
(speciﬁcally MSU and CPPD) that have relevance to OA pathogenesis.
Methods: Synovial tissue specimens for establishment of FLS lines were
obtained from asymptomatic organ donors with no documented his-
tory of joint disease via IRB approved protocols. Recombinant human
CD14 (0.5 ug /ml, based on concentrations found in patient SF) in
combination with MSU crystals or CCPD crystals (both from Invivogen)
used in concentrations from 0.05 to 50 ug/ml were used to stimulate
primary FLS at passage 4. Stimulationwas measured by IL-8 release into
the culture media measured by ELISA (Invitrogen). Responses of HEK-
293 cell lines transfected with TLR-2 or TLR-4 were measured to
determine the dependence of observed responses on these receptors. A
peptide inhibitor of TLR-4 signaling (CLI-095, Invivogen) was used to
test whether FLS responses were related to TLR-4 mediated mediated
signaling.
Results: CPPD, but not MSU, was able to stimulate IL-8 production from
FLS cells in the presence of CD14. Experiments in three separate cell
lines demonstrated that addition of CD14 augmented the effect of CPPD
down to a concentration of 0.5 ug/ml (repeated measures ANOVA, p ¼
0.02 at 0.5 ug/ml, with CD14 vs. without CD14). CPPD, in combination
with rhCD14, was able to stimulate HEK-293 cells transfected with TLR-
4, but not TLR-2. In FLS cells, addition of the TLR-4 inhibitor CLI-095
prevented the response to CD14þCPPD.
Conclusions: CPPD crystals stimulate FLS production of IL-8 in the
presence of CD14. Our experiments indicate that TLR-4 is involved in
this response. As CPPD crystals are known to be common in the joint
tissues and ﬂuid of patients affected by OA, it is possible that the
synovial response to these crystals may contribute to inﬂammation in
OA.
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ANTI-INFLAMMATORY EFFECTS OF LANSOPRAZOLE BY INHIBITING
NITRIC OXIDE PRODUCTION VIA REACTIVE OXYGEN SPECIES IN
MURINE MACROPHAGE RAW 264.7 CELLS
S. Ichimaru, S. Nakagawa, Y. Arai, S. Tsuchida, H. Inoue, T. Matsuki,
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Purpose: Lansoprazole (LPZ), proton pump inhibitor, is widely used
clinically to treat gastrointestinal mucosal disorders. The mucosal-
protective effects of PPIs are due primarily to their inhibition of P-
ATPase. More recently, however, PPIs were shown to have local
pleiotropic effects in the gastric mucosa, including having anti-
apoptotic effects, inhibiting the generation of reactive oxygen species
(ROS), and inhibiting the expression of macrophage adhesion mole-
cules. Aberrantly activated macrophages overproduce inﬂammatorymediators such as nitric oxide (NO) and prostaglandin E2 (PGE2),
both of which are involved in the pathogenesis of many inﬂamma-
tory diseases including rheumatoid arthritis. Agents that target
macrophages, inhibiting the secretion of multiple inﬂammatory
mediators, may provide a breakthrough as novel therapy for patients
with inﬂammatory disorders. The purpose of this study is to inves-
tigate the effects of LPZ on activated macrophages and the mecha-
nisms by which LPZ inhibits the production of inﬂammatory
mediators such as NO and PGE2.
Methods: RAW264.7 murine macrophages were used in this study. The
cells were incubated with various concentrations of LPZ for 24 h and the
cell viability was evaluated by MTS assay. The cells were treated with
various concentrations of LPZ in the presence or absence of lip-
opolysaccharide (LPS), and the concentration of NO and PGE2 in
supernatant was measured. iNOS and COX-2 expression were analysed
by Western blotting. We used RT-PCR to determine whether P-ATPase
mRNA is expressed in RAW264.7 cells. We measured intracellular ROS
concentrations of LPS-stimulated cells by ﬂow cytometry in the pres-
ence or absence of 100mM LPZ. To determine whether LPS-induced ROS
affects NO and PGE2 production, we measured NO and PGE2 levels after
controlling ROS levels using antioxidants such as N-acetyl-L-cysteine
(NAC), an ROS scavenger, and Diphenylene iodonium (DPI), an inhibitor
of NADPH oxidase.
Results: LPZ, at concentrations of 0–100 mM, had no effects on the
viability of RAW264.7 cells. LPZ inhibited the LPS-induced production of
NO and PGE2 in a concentration-dependent manner. The expression of
iNOS and COX-2 was also suppressed by LPZ at a concentration of 100
mM. P-ATPase expressed in mouse gastric mucosal tissue but not in
RAW264.7 cells. In addition, LPZ alone did not alter ROS levels in the
absence of LPS, whereas preincubationwith LPZ prior to LPS stimulation
signiﬁcantly reduced the levels of ROS. NAC had no effect on NO levels
and, DPI, an inhibitor of NADPH oxidase, decreased NO levels, but nei-
ther NAC nor DPI altered PGE2 levels.
Conclusions: We found that LPZ not only inhibited NO and PGE2
production but also suppressed iNOS and COX-2 expression. This
result suggests that LPZ exerts anti-inﬂammatory effects by sup-
pressing the expression of iNOS and COX-2. We found that LPS
stimulation increased the production of both ROS and NO and that
DPI suppresses LPS-induced NO production. These ﬁndings suggest
that, LPS stimulation increases ROS production and is associated
with inﬂammatory responses by inducing NO production. NAC did
not inhibit LPS-induced NO production, indicating that once ROS has
been produced, it is difﬁcult to control NO production. Our ﬁndings,
showing that LPZ suppressed the inﬂammatory activity of activated
macrophages in vitro, suggest that LPZ may be promising in the
treatment of inﬂammatory diseases involving activated macrophages
including rheumatoid arthritis. Studies in animal models may show
these therapeutic effects.
